ALAVITA PHARMACEUTICALS, INC.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 12, 2010 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 166 Total Citation Count
- Feb 21, 2002 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7635676 Modified annexin proteins and methods for their use in organ transplantationExpiredNov 03, 05Dec 22, 09[A61K]
2009/0291,086 Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral IschemiaAbandonedMay 21, 09Nov 26, 09[A61K, A61P]
7407475 Modified annexin proteins, and methods and compositions for using themExpiredApr 20, 05Aug 05, 08[A61K]
2007/0207,150 MODIFIED ANNEXIN PROTEINS AND METHODS FOR THEIR USE IN ORGAN TRANSPLANTATION AND IN PREVENTION OF THROMBOSIS AND REPERFUSION INJURYAbandonedDec 19, 06Sep 06, 07[A61K, C07K]
6982154 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell diseaseExpiredAug 01, 03Jan 03, 06[A61K, C12P]
6962903 Modified annexin proteins and methods for preventing thrombosisExpiredFeb 21, 02Nov 08, 05[A61K, C08L, C07K]
2005/0222,030 Modified annexin proteins and methods for preventing thrombosisAbandonedMar 10, 05Oct 06, 05[A61K, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.